Cargando…
Glucocorticoids and Antivirals for HBV Reactivation in Onco-Hematologic Patients.
Patients with inactive or occult hepatitis B virus infection and onco-hematological malignancies are at risk of hepatitis flare, hepatic failure and death due to chemotherapy-mediated reactivation. Nucleot(s)ide analogues can reduce reactivation risks and/or hepatitis. However, immuno-mediated pheno...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033103/ https://www.ncbi.nlm.nih.gov/pubmed/21415953 http://dx.doi.org/10.4084/MJHID.2010.035 |